AI and machine learning tools speed up Alzheimer’s drug discovery at Indiana University

A new $6 million research initiative at Indiana University aims to develop AI tools to accelerate the search for Alzheimer’s and dementia treatments.
The five-year project unites researchers from the School of Medicine and the Luddy School of Informatics, Computing and Engineering.
The goal is to use AI and machine learning to significantly enhance the evaluation of potential drug candidates, thus speeding up the drug discovery process.
Artificial intelligence will combine with traditional chemistry and medical research methods to identify new chemical structures that could interact with Alzheimer’s-related proteins.
There is potential for the new AI-powered approach to transform drug discovery by being able to efficiently screen billions of compounds, thereby prioritizing promising leads.
While symptom-managing medications exist, there is a pressing need for treatments that can halt or reverse Alzheimer’s disease, and AI may bridge this critical gap.
The initiative operates in parallel with the TREAT-AD program at Indiana University, also focused on finding new drug targets for Alzheimer’s disease.
Researchers remain hopeful that this new approach will yield the next generation of effective treatments for Alzheimer’s and related forms of dementia.